Morepen Laboratories Limited

BSE: 500288 NSE: MOREPENLAB
Morepen Laboratories Limited - pharma in Himachal Pradesh, Himachal Pradesh, India. FY 2026 financials and compliance.
CIN L24231HP1984PLC006028 Incorporated 01 December 1984 ROC Himachal Pradesh HQ Himachal Pradesh, Himachal Pradesh, India
Active Listed - NSE: MOREPENLAB · BSE: 500288 Public Limited Company pharma
Data last updated
Revenue · FY 2026
₹1,805.69 Cr
▼ 0.32% YoY
EBITDA · FY 2026
₹146.94 Cr
▼ 23.64% YoY
Net profit · FY 2026
₹94.88 Cr
▼ 19.61% YoY
Authorised capital
₹250 Cr
Registered with MCA
Paid-up capital
₹109.58 Cr
Issued & subscribed
Open charges
₹61.36 Cr
Satisfied ₹2,644.6 Cr
Company age
42 yrs
Est. 1984
Employees · EPFO
557
Latest available

About Morepen Laboratories Limited

Data last updated: 06 April 2026

Morepen Laboratories Limited is a public limited company based in Himachal Pradesh, Himachal Pradesh, India. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 01 December 1984, the company has been in operation for over 42 years.

Registered with ROC Himachal Pradesh under CIN L24231HP1984PLC006028. Listed on BSE: 500288 and NSE: MOREPENLAB.

Capital: an authorised share capital of ₹250 Cr and a paid-up capital of ₹109.58 Cr. Formerly known as Morepen Laboratories Private Limited. It is led by directors including Savita and Praveen Dutt Kumar.

Last AGM: 06 September 2025. Financial statements filed for year ended 31 March 2025. Office: Village Morepen Nalagarh Road Near Baddi Distt Solan, Himachal Pradesh, Himachal Pradesh, India – 173205.

As per the financials filed for FY 2025, the company reported a revenue of ₹1,829.94 Cr, a growth of 7% compared to the previous year.

The company has a workforce of approximately 557 employees as per the latest available data. Its group structure includes 6 subsidiaries.

The company is associated with 1 brand - Morepen Laboratories. As per MCA filings, the company has open charges of ₹61.36 Cr and satisfied charges of ₹2,644.6 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website morepen.com.

Company Details of Morepen Laboratories Limited
CIN L24231HP1984PLC006028
Registration Number 006028
Incorporation Date 01 December 1984
ROC Himachal Pradesh
Listing Status Listed (BSE: 500288, NSE: MOREPENLAB)
Company Status Active
Date of Last AGM 06 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Sushil Suri Managing Director Sanjay Suri Whole-Time Director Savita Director
Contact Details
  • Email
    *****@*****.com
  • Telephone
    +91-****-******
  • Website
    morepen.com
  • Social Media
  • Registered Address
    Village Morepen Nalagarh Road Near Baddi Distt Solan, Himachal Pradesh, Himachal Pradesh, India – 173205
  • Industry
    Pharma, API Manufacturers
Company report
Morepen Laboratories Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Morepen Laboratories Limited report

Financials, compliance, directors, charges, ownership and filings for Morepen Laboratories Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Morepen Laboratories Limited

Morepen Laboratories Limited operates one associated brand: Morepen Laboratories. These brands represent Morepen Laboratories Limited's diversified market presence and brand portfolio.

Brand Description Website
Morepen Laboratories
API, formulations, diagnostics, and FMHG products are manufactured and marketed. morepen.com

Business Activity of Morepen Laboratories Limited

Morepen Laboratories Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products *********

Auditor Details of Morepen Laboratories Limited

Morepen Laboratories Limited is audited by S P Babuta & Associates (ICAI peer reviewed, certificate valid till 2028-06-30) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
S P Babuta & Associates (ICAI peer reviewed, certificate valid till 2028-06-30) FY 2026 Declaration of unmodified opinion

Board of Directors of Morepen Laboratories Limited

Morepen Laboratories Limited is currently managed by 8 directors, with 15 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Savita
Also directs: Bls International Services Limited, Bls It Services Private Limited, Bls E-Solutions Private Limited
Director 22 Jun 2020 6 Years 0 Months Current
Praveen Dutt Kumar
Also directs: Nexiris Global Private Limited, Si Infratel Private Limited
Director 13 Aug 2019 6 Years 10 Months Current
Sushil Suri
Also directs: Bliss & Blue Ventures Llp, Shivalik Pesticides And Chemicals Pvt Ltd, Morepen Medipath Limited and 5 more
Managing Director 20 Oct 2015 10 Years 8 Months Current
Sharad Jain
Also directs: Dr. Morepen Limited
Director 27 Aug 2024 1 Years 10 Months Current
Sanjay Suri
Also directs: Bliss & Blue Ventures Llp, Shivalik Pesticides And Chemicals Pvt Ltd, Morepen Medipath Limited and 5 more
Whole-Time Director 13 Aug 2019 6 Years 10 Months Current
Ranjit Khattar
Also directs: Xpress Funding Advisors Llp, Dr. Morepen Limited, Eldeco Sohna Projects Limited and 5 more
Director 12 Aug 2024 1 Years 10 Months Current
Showing 6 of 8 current directors. View all directors

Financials of Morepen Laboratories Limited FY 2026 filings available

Morepen Laboratories Limited reported revenue of ₹1,805.69 Cr (down 0.32% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue · FY 2026
₹1,805.69 Cr ▼ 0.32%
Profit · FY 2026
₹94.88 Cr ▼ 19.61%
EBITDA · FY 2026
₹146.94 Cr ▼ 23.64%
Revenue₹ Cr · Consolidated01,0002,000FY 2020: ₹853 Cr853FY 2020FY 2021: ₹1,188 Cr · +39.3% YoY1,188+39.3%FY 2021FY 2022: ₹1,547 Cr · +30.2% YoY1,547+30.2%FY 2022FY 2023: ₹1,418 Cr · -8.4% YoY1,418-8.4%FY 2023FY 2024: ₹1,690 Cr · +19.3% YoY1,690+19.3%FY 2024FY 2025: ₹1,812 Cr · +7.2% YoY1,812+7.2%FY 2025FY 2026: ₹1,806 Cr · -0.3% YoY1,806-0.3%FY 2026
Net Profit₹ Cr · Consolidated050100150FY 2020: ₹34 Cr33.6FY 2020FY 2021: ₹97 Cr · +189.1% YoY97.1+189.1%FY 2021FY 2022: ₹102 Cr · +4.7% YoY102+4.7%FY 2022FY 2023: ₹39 Cr · -62% YoY38.7-62%FY 2023FY 2024: ₹96 Cr · +148.6% YoY96.2+148.6%FY 2024FY 2025: ₹118 Cr · +22.7% YoY118+22.7%FY 2025FY 2026: ₹95 Cr · -19.6% YoY94.9-19.6%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year0200400600Q1'25: ₹455 Cr · +13.5% YoY455+13.5%Q1'25Q2'25: ₹438 Cr · +3.8% YoY438+3.8%Q2'25Q3'25: ₹453 Cr · +1.9% YoY453+1.9%Q3'25Q4'25: ₹466 Cr · +10.1% YoY466+10.1%Q4'25Q1'26: ₹425 Cr · -6.6% YoY425-6.6%Q1'26Q2'26: ₹412 Cr · -6% YoY412-6%Q2'26Q3'26: ₹484 Cr · +6.9% YoY484+6.9%Q3'26Q4'26: ₹485 Cr · +4% YoY485+4%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue from Operations ₹1,805.69 Cr ₹1,811.58 Cr ₹1,690.43 Cr ₹1,417.53 Cr ₹1,546.83 Cr ₹1,188.06 Cr ₹853.07 Cr
Other Income ₹21.31 Cr ₹18.36 Cr ₹13.97 Cr ₹6.13 Cr ₹10.31 Cr ₹12.07 Cr ₹9.48 Cr
Total Income ₹1,827.01 Cr ₹1,829.94 Cr ₹1,704.4 Cr ₹1,423.66 Cr ₹1,557.13 Cr ₹1,200.13 Cr ₹862.55 Cr
Cost of Materials Consumed ₹1,043.11 Cr ₹999.18 Cr ₹883.31 Cr ₹781.41 Cr ₹797.13 Cr ₹617.93 Cr ₹413.22 Cr
Purchases of Stock-in-Trade ₹82.46 Cr ₹207.25 Cr ₹177 Cr ₹157.85 Cr ₹262.23 Cr ₹204.2 Cr ₹154.43 Cr
Changes in Inventories -₹2.15 Cr -₹47.12 Cr ₹2.11 Cr ₹16.48 Cr -₹10.04 Cr -₹41.58 Cr -₹10.23 Cr
Employee Benefit Expense ₹232.74 Cr ₹208.91 Cr ₹181.47 Cr ₹154.68 Cr ₹164.25 Cr ₹135.59 Cr ₹109.91 Cr
Finance Costs ₹16.41 Cr ₹8.34 Cr ₹3.71 Cr ₹1.98 Cr -₹7.37 Cr ₹1.79 Cr ₹1.98 Cr
Depreciation & Amortisation ₹36.43 Cr ₹28.98 Cr ₹33.47 Cr ₹27.93 Cr ₹27.64 Cr ₹30.28 Cr ₹36.91 Cr
Other Expenses ₹323.91 Cr ₹269.28 Cr ₹287.92 Cr ₹227.57 Cr ₹196.59 Cr ₹153.4 Cr ₹117.23 Cr
Total Expenses ₹1,732.91 Cr ₹1,674.83 Cr ₹1,568.99 Cr ₹1,367.91 Cr ₹1,430.43 Cr ₹1,101.61 Cr ₹823.44 Cr
Profit Before Exceptional Items & Tax ₹94.09 Cr ₹155.11 Cr ₹135.42 Cr ₹55.76 Cr ₹126.7 Cr ₹98.51 Cr ₹39.11 Cr
Exceptional Items ₹25.83 Cr ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹119.92 Cr ₹155.11 Cr ₹135.42 Cr ₹55.76 Cr ₹126.7 Cr ₹98.51 Cr ₹39.11 Cr
Total Tax Expense ₹24.27 Cr ₹37.09 Cr ₹38.8 Cr ₹17.08 Cr ₹25.02 Cr ₹1.42 Cr ₹5.53 Cr
Net Profit ₹94.88 Cr ₹118.02 Cr ₹96.16 Cr ₹38.68 Cr ₹101.68 Cr ₹97.09 Cr ₹33.58 Cr
  attributable to Owners ₹0 ₹0 ₹0 - - - ₹0
  attributable to NCI ₹0 ₹0 ₹0 - - - ₹0
Other Comprehensive Income ₹6.19 Cr ₹25.37 Lakh -₹1.84 Cr -₹1.48 Cr -₹37.1 Lakh -₹14.72 Lakh -₹2.61 Cr
Total Comprehensive Income ₹101.07 Cr ₹118.27 Cr ₹94.32 Cr ₹37.19 Cr ₹101.31 Cr ₹96.94 Cr ₹30.97 Cr
EBITDA (computed) ₹146.94 Cr ₹192.43 Cr ₹172.6 Cr ₹85.67 Cr ₹146.98 Cr ₹130.58 Cr ₹78 Cr
Basic EPS ₹1.73 ₹2.20 ₹1.88 ₹0.77 ₹2.26 ₹2.16 ₹0.75
Diluted EPS ₹1.73 ₹2.20 ₹1.88 ₹0.77 ₹1.96 ₹2.15 ₹0.75
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹1,936.12 Cr ₹1,778.1 Cr ₹1,293.21 Cr ₹1,110.5 Cr
Non-current Assets ₹772.51 Cr ₹618.73 Cr ₹404.16 Cr ₹354.33 Cr
Current Assets ₹1,163.61 Cr ₹1,159.37 Cr ₹889.04 Cr ₹756.16 Cr
Property, Plant & Equipment ₹381.16 Cr ₹316.51 Cr ₹213.2 Cr ₹167 Cr
Inventories ₹271.83 Cr ₹299.97 Cr ₹248.59 Cr ₹228.89 Cr
Trade Receivables ₹333.14 Cr ₹324.76 Cr ₹324.94 Cr ₹263.25 Cr
Cash & Equivalents ₹31.19 Cr ₹27.38 Cr ₹16.95 Cr ₹21.67 Cr
Equity (Net Worth) ₹1,247.09 Cr ₹1,186.96 Cr ₹847.23 Cr ₹752.45 Cr
Equity Share Capital ₹109.58 Cr ₹109.58 Cr ₹102.23 Cr ₹102.23 Cr
Borrowings (Non-current) ₹133.6 Cr ₹25.76 Cr ₹3.36 Cr ₹93.35 Lakh
Borrowings (Current) ₹61.09 Cr ₹53.63 Cr ₹25.64 Cr ₹24.23 Cr
Total Debt (computed) ₹194.69 Cr ₹79.39 Cr ₹29 Cr ₹25.16 Cr
Current Liabilities ₹490.3 Cr ₹500.65 Cr ₹402.04 Cr ₹321.16 Cr
Total Liabilities ₹689.03 Cr ₹591.14 Cr ₹445.98 Cr ₹358.05 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹32.64 Cr ₹32.06 Cr ₹73.37 Cr -₹91.17 Cr -₹57.76 Cr
Investing Cash Flow -₹123.42 Cr -₹321.51 Cr -₹83.3 Cr -₹46.51 Cr -₹31.68 Cr
Financing Cash Flow ₹97.4 Cr ₹299.89 Cr ₹5.2 Cr ₹143.54 Cr ₹63.85 Cr
Capital Expenditure ₹85.52 Cr ₹124.03 Cr ₹71.38 Cr ₹35.62 Cr ₹45.45 Cr
Free Cash Flow (computed) -₹52.88 Cr -₹91.98 Cr ₹1.99 Cr -₹126.79 Cr -₹103.2 Cr
Dividends Paid ₹10.86 Cr ₹0 ₹0 ₹0 ₹0
Net Change in Cash ₹6.62 Cr ₹10.44 Cr -₹4.72 Cr ₹5.86 Cr -₹25.58 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹484.72 Cr ₹484.16 Cr ₹411.58 Cr ₹425.24 Cr ₹465.85 Cr ₹452.78 Cr ₹437.73 Cr ₹455.22 Cr ₹423.07 Cr ₹444.55 Cr ₹421.77 Cr ₹401.04 Cr
Other Income ₹8.46 Cr ₹3.81 Cr ₹4.64 Cr ₹4.41 Cr ₹4.61 Cr ₹5.34 Cr ₹4.99 Cr ₹3.43 Cr ₹4.24 Cr ₹4.07 Cr ₹3.24 Cr ₹2.42 Cr
Total Income ₹493.18 Cr ₹487.97 Cr ₹416.21 Cr ₹429.65 Cr ₹470.46 Cr ₹458.12 Cr ₹442.71 Cr ₹458.64 Cr ₹427.32 Cr ₹448.62 Cr ₹425.01 Cr ₹403.46 Cr
Cost of Materials Consumed ₹290.58 Cr ₹294.19 Cr ₹220.63 Cr ₹237.71 Cr ₹268.43 Cr ₹239.52 Cr ₹256.22 Cr ₹235.01 Cr ₹220.26 Cr ₹235.6 Cr ₹227.36 Cr ₹200.08 Cr
Purchases of Stock-in-Trade ₹17.67 Cr ₹15.77 Cr ₹31.98 Cr ₹17.04 Cr ₹71.31 Cr ₹40.67 Cr ₹39.29 Cr ₹55.97 Cr ₹30.08 Cr ₹45.6 Cr ₹43.61 Cr ₹57.71 Cr
Changes in Inventories -₹8.72 Cr -₹12.62 Cr ₹11.58 Cr ₹7.62 Cr -₹23.98 Cr ₹10.45 Cr -₹25.41 Cr -₹8.18 Cr ₹6.18 Cr -₹9.16 Cr ₹1.8 Cr ₹3.29 Cr
Employee Benefit Expense ₹58.76 Cr ₹62.09 Cr ₹56.65 Cr ₹55.24 Cr ₹57.01 Cr ₹54.28 Cr ₹49.67 Cr ₹47.96 Cr ₹47.94 Cr ₹46.8 Cr ₹43.32 Cr ₹43.41 Cr
Finance Costs ₹3.88 Cr ₹4.32 Cr ₹4.18 Cr ₹4.04 Cr ₹4.67 Cr ₹1.34 Cr ₹1.18 Cr ₹1.15 Cr ₹79.8 Lakh ₹2.17 Cr ₹45.79 Lakh ₹28.27 Lakh
Depreciation & Amortisation ₹5.75 Cr ₹10.38 Cr ₹11.28 Cr ₹9.03 Cr ₹16.47 Cr ₹4.93 Cr ₹1.86 Cr ₹5.73 Cr ₹9.62 Cr ₹8.45 Cr ₹7.69 Cr ₹7.71 Cr
Other Expenses ₹101.99 Cr ₹78.42 Cr ₹60.04 Cr ₹83.47 Cr ₹50.85 Cr ₹71.71 Cr ₹73.89 Cr ₹72.83 Cr ₹70.23 Cr ₹75.15 Cr ₹72.09 Cr ₹70.45 Cr
Total Expenses ₹469.89 Cr ₹452.55 Cr ₹396.34 Cr ₹414.13 Cr ₹444.75 Cr ₹422.91 Cr ₹396.69 Cr ₹410.48 Cr ₹385.11 Cr ₹404.6 Cr ₹396.32 Cr ₹382.94 Cr
Profit Before Exceptional Items & Tax ₹23.29 Cr ₹35.42 Cr ₹19.87 Cr ₹15.52 Cr ₹25.71 Cr ₹35.21 Cr ₹46.02 Cr ₹48.17 Cr ₹42.2 Cr ₹44.02 Cr ₹28.68 Cr ₹20.51 Cr
Exceptional Items ₹0 ₹0 ₹25.83 Cr ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹23.29 Cr ₹35.42 Cr ₹45.69 Cr ₹15.52 Cr ₹25.71 Cr ₹35.21 Cr ₹46.02 Cr ₹48.17 Cr ₹42.2 Cr ₹44.02 Cr ₹28.68 Cr ₹20.51 Cr
Total Tax Expense ₹7.59 Cr ₹7.93 Cr ₹4.65 Cr ₹4.11 Cr ₹5.4 Cr ₹8.52 Cr ₹11.17 Cr ₹12 Cr ₹13.46 Cr ₹12.03 Cr ₹7.43 Cr ₹5.88 Cr
Net Profit ₹15.74 Cr ₹27.51 Cr ₹40.87 Cr ₹10.75 Cr ₹20.32 Cr ₹26.69 Cr ₹34.85 Cr ₹36.17 Cr ₹28.28 Cr ₹31.99 Cr ₹21.26 Cr ₹14.63 Cr
  attributable to Owners ₹0 ₹0 ₹0 ₹0 ₹0 - - - ₹0 - ₹0 -
  attributable to NCI ₹0 ₹0 ₹0 ₹0 ₹0 - - - ₹0 - ₹0 -
Other Comprehensive Income ₹6.36 Cr ₹58.81 Lakh -₹1.35 Cr ₹59 Lakh -₹80.34 Lakh -₹40.36 Lakh -₹1.11 Cr ₹2.57 Cr -₹2.03 Cr -₹46,000 -₹81.52 Lakh ₹1.01 Cr
Total Comprehensive Income ₹22.11 Cr ₹28.1 Cr ₹39.52 Cr ₹11.34 Cr ₹19.51 Cr ₹26.28 Cr ₹33.74 Cr ₹38.74 Cr ₹26.25 Cr ₹31.99 Cr ₹20.44 Cr ₹15.65 Cr
EBITDA (computed) ₹32.91 Cr ₹50.12 Cr ₹35.33 Cr ₹28.58 Cr ₹46.85 Cr ₹41.48 Cr ₹49.06 Cr ₹55.05 Cr ₹52.62 Cr ₹54.64 Cr ₹36.83 Cr ₹28.51 Cr
Basic EPS ₹0.28 ₹0.50 ₹0.75 ₹0.20 ₹0.35 ₹0.49 ₹0.65 ₹0.71 ₹0.54 ₹0.63 ₹0.42 ₹0.29
Diluted EPS ₹0.28 ₹0.50 ₹0.75 ₹0.20 ₹0.35 ₹0.49 ₹0.65 ₹0.71 ₹0.54 ₹0.63 ₹0.42 ₹0.29
Latest 12 quarters shown of 24 on record.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue from Operations ₹1,681.2 Cr ₹1,554.54 Cr ₹1,537.59 Cr ₹1,338.88 Cr ₹1,449.27 Cr ₹1,112.42 Cr ₹791.99 Cr
Other Income ₹21.5 Cr ₹15.72 Cr ₹12.57 Cr ₹5.76 Cr ₹10.24 Cr ₹11.77 Cr ₹9.42 Cr
Total Income ₹1,702.69 Cr ₹1,570.25 Cr ₹1,550.16 Cr ₹1,344.64 Cr ₹1,459.5 Cr ₹1,124.2 Cr ₹801.4 Cr
Cost of Materials Consumed ₹1,043.11 Cr ₹999.18 Cr ₹883.31 Cr ₹781.41 Cr ₹797.13 Cr ₹617.93 Cr ₹413.22 Cr
Purchases of Stock-in-Trade ₹15.02 Cr ₹20.81 Cr ₹61.84 Cr ₹105.07 Cr ₹191.68 Cr ₹160.67 Cr ₹115.45 Cr
Changes in Inventories ₹3.23 Cr -₹44.36 Cr ₹5.13 Cr ₹16.54 Cr ₹1.74 Cr -₹41.98 Cr -₹7.58 Cr
Employee Benefit Expense ₹206.28 Cr ₹177.22 Cr ₹160.28 Cr ₹146.19 Cr ₹150 Cr ₹123.2 Cr ₹98.07 Cr
Finance Costs ₹16.1 Cr ₹7.1 Cr ₹3.51 Cr ₹1.98 Cr -₹7.37 Cr ₹1.79 Cr ₹1.97 Cr
Depreciation & Amortisation ₹29.31 Cr ₹24.44 Cr ₹21.9 Cr ₹18.01 Cr ₹21.19 Cr ₹28.11 Cr ₹34.43 Cr
Other Expenses ₹301.48 Cr ₹248.27 Cr ₹265.22 Cr ₹212.4 Cr ₹179.58 Cr ₹140.23 Cr ₹108.36 Cr
Total Expenses ₹1,614.52 Cr ₹1,432.67 Cr ₹1,401.18 Cr ₹1,281.6 Cr ₹1,333.96 Cr ₹1,029.95 Cr ₹763.92 Cr
Profit Before Exceptional Items & Tax ₹88.17 Cr ₹137.59 Cr ₹148.98 Cr ₹63.04 Cr ₹125.54 Cr ₹94.25 Cr ₹37.48 Cr
Exceptional Items ₹1.1 Cr ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹89.26 Cr ₹137.59 Cr ₹148.98 Cr ₹63.04 Cr ₹125.54 Cr ₹94.25 Cr ₹37.48 Cr
Total Tax Expense ₹23.21 Cr ₹36.01 Cr ₹38.04 Cr ₹16.8 Cr ₹24.48 Cr ₹0 ₹5.15 Cr
Net Profit ₹66.06 Cr ₹101.58 Cr ₹110.94 Cr ₹46.24 Cr ₹101.06 Cr ₹94.25 Cr ₹32.33 Cr
Other Comprehensive Income ₹6.06 Cr ₹17.23 Lakh -₹2.03 Cr -₹1.45 Cr -₹36.85 Lakh -₹27.26 Lakh -₹2.54 Cr
Total Comprehensive Income ₹72.11 Cr ₹101.75 Cr ₹108.91 Cr ₹44.8 Cr ₹100.69 Cr ₹93.98 Cr ₹29.79 Cr
EBITDA (computed) ₹133.57 Cr ₹169.13 Cr ₹174.38 Cr ₹83.03 Cr ₹139.37 Cr ₹124.15 Cr ₹73.88 Cr
Basic EPS ₹1.21 ₹1.90 ₹2.17 ₹0.92 ₹2.25 ₹2.10 ₹0.72
Diluted EPS ₹1.21 ₹1.90 ₹2.17 ₹0.92 ₹1.94 ₹2.09 ₹0.72
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹1,907.66 Cr ₹1,721.2 Cr ₹1,279.31 Cr ₹1,105.54 Cr
Non-current Assets ₹669.19 Cr ₹614.42 Cr ₹436.4 Cr ₹374.69 Cr
Current Assets ₹1,238.47 Cr ₹1,106.78 Cr ₹842.91 Cr ₹730.85 Cr
Property, Plant & Equipment ₹307.52 Cr ₹315.89 Cr ₹212.44 Cr ₹166.09 Cr
Inventories ₹154.26 Cr ₹286.39 Cr ₹220.15 Cr ₹211.35 Cr
Trade Receivables ₹333.19 Cr ₹293.75 Cr ₹316.89 Cr ₹255.47 Cr
Cash & Equivalents ₹10.57 Cr ₹24.43 Cr ₹15.3 Cr ₹21.26 Cr
Equity (Net Worth) ₹1,242.76 Cr ₹1,181.5 Cr ₹889.02 Cr ₹780.11 Cr
Equity Share Capital ₹109.58 Cr ₹109.58 Cr ₹102.23 Cr ₹102.23 Cr
Borrowings (Non-current) ₹132.86 Cr ₹25.76 Cr ₹3.36 Cr ₹93.35 Lakh
Borrowings (Current) ₹60.73 Cr ₹53.2 Cr ₹24.83 Cr ₹24.23 Cr
Total Debt (computed) ₹193.59 Cr ₹78.96 Cr ₹28.19 Cr ₹25.16 Cr
Current Liabilities ₹346.29 Cr ₹461.56 Cr ₹352.64 Cr ₹290.98 Cr
Total Liabilities ₹664.9 Cr ₹539.7 Cr ₹390.28 Cr ₹325.43 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹20.47 Cr ₹29.08 Cr ₹77.36 Cr -₹102.12 Cr -₹66.38 Cr
Investing Cash Flow -₹119.02 Cr -₹280.42 Cr -₹83.6 Cr -₹36.2 Cr -₹22.64 Cr
Financing Cash Flow ₹97.12 Cr ₹260.47 Cr ₹28.22 Lakh ₹144.2 Cr ₹63.93 Cr
Capital Expenditure ₹83.76 Cr ₹123.95 Cr ₹71.23 Cr ₹35.55 Cr ₹45.16 Cr
Free Cash Flow (computed) -₹63.29 Cr -₹94.88 Cr ₹6.13 Cr -₹137.66 Cr -₹111.54 Cr
Dividends Paid ₹10.86 Cr ₹0 ₹0 ₹0 ₹0
Net Change in Cash -₹1.43 Cr ₹9.12 Cr -₹5.96 Cr ₹5.88 Cr -₹25.09 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹462.81 Cr ₹457.57 Cr ₹369.53 Cr ₹391.28 Cr ₹381.94 Cr ₹403.25 Cr ₹383.7 Cr ₹385.64 Cr ₹392.6 Cr ₹394.63 Cr ₹381.26 Cr ₹369.1 Cr
Other Income ₹8.82 Cr ₹3.93 Cr ₹4.65 Cr ₹4.09 Cr ₹3.14 Cr ₹4.87 Cr ₹4.63 Cr ₹3.07 Cr ₹3.99 Cr ₹3.66 Cr ₹2.84 Cr ₹2.08 Cr
Total Income ₹471.63 Cr ₹461.5 Cr ₹374.18 Cr ₹395.38 Cr ₹385.08 Cr ₹408.13 Cr ₹388.33 Cr ₹388.72 Cr ₹396.59 Cr ₹398.29 Cr ₹384.1 Cr ₹371.19 Cr
Cost of Materials Consumed ₹290.58 Cr ₹294.19 Cr ₹220.63 Cr ₹237.71 Cr ₹268.43 Cr ₹239.52 Cr ₹256.22 Cr ₹235.01 Cr ₹220.26 Cr ₹235.6 Cr ₹227.36 Cr ₹200.08 Cr
Purchases of Stock-in-Trade ₹5 Cr ₹1.62 Cr ₹7.09 Cr ₹1.31 Cr ₹5.77 Cr ₹5.77 Cr ₹3.47 Cr ₹5.81 Cr ₹2.33 Cr ₹9 Cr ₹17.89 Cr ₹32.62 Cr
Changes in Inventories -₹5.52 Cr -₹10.81 Cr ₹9.73 Cr ₹9.83 Cr -₹21.46 Cr ₹12.41 Cr -₹26.09 Cr -₹9.22 Cr ₹11.3 Cr -₹9.24 Cr ₹45.1 Lakh ₹2.62 Cr
Employee Benefit Expense ₹54.37 Cr ₹55.61 Cr ₹49.61 Cr ₹46.69 Cr ₹48.15 Cr ₹46.3 Cr ₹42.84 Cr ₹39.94 Cr ₹40.17 Cr ₹40.32 Cr ₹38.73 Cr ₹41.07 Cr
Finance Costs ₹3.87 Cr ₹4.31 Cr ₹4.11 Cr ₹3.81 Cr ₹3.74 Cr ₹1.27 Cr ₹1.05 Cr ₹1.04 Cr ₹72.77 Lakh ₹2.04 Cr ₹45.49 Lakh ₹28.27 Lakh
Depreciation & Amortisation ₹63.23 Lakh ₹10.09 Cr ₹10.7 Cr ₹7.88 Cr ₹12.25 Cr ₹4.81 Cr ₹3.79 Cr ₹3.59 Cr ₹6.69 Cr ₹5.51 Cr ₹4.81 Cr ₹4.89 Cr
Other Expenses ₹95.07 Cr ₹75.07 Cr ₹54.54 Cr ₹76.8 Cr ₹50.9 Cr ₹67.68 Cr ₹64.19 Cr ₹65.5 Cr ₹62.4 Cr ₹67.85 Cr ₹67.06 Cr ₹67.9 Cr
Total Expenses ₹444 Cr ₹430.08 Cr ₹356.41 Cr ₹384.02 Cr ₹367.78 Cr ₹377.75 Cr ₹345.48 Cr ₹341.67 Cr ₹343.88 Cr ₹351.07 Cr ₹356.76 Cr ₹349.47 Cr
Profit Before Exceptional Items & Tax ₹27.63 Cr ₹31.42 Cr ₹17.77 Cr ₹11.35 Cr ₹17.3 Cr ₹30.38 Cr ₹42.86 Cr ₹47.05 Cr ₹52.71 Cr ₹47.22 Cr ₹27.33 Cr ₹21.71 Cr
Exceptional Items ₹0 ₹0 ₹1.1 Cr ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹27.63 Cr ₹31.42 Cr ₹18.86 Cr ₹11.35 Cr ₹17.3 Cr ₹30.38 Cr ₹42.86 Cr ₹47.05 Cr ₹52.71 Cr ₹47.22 Cr ₹27.33 Cr ₹21.71 Cr
Total Tax Expense ₹7.5 Cr ₹7.93 Cr ₹4.49 Cr ₹3.29 Cr ₹5.39 Cr ₹7.69 Cr ₹10.93 Cr ₹12 Cr ₹12.75 Cr ₹12.02 Cr ₹7.41 Cr ₹5.86 Cr
Net Profit ₹20.12 Cr ₹23.5 Cr ₹14.38 Cr ₹8.06 Cr ₹11.91 Cr ₹22.69 Cr ₹31.93 Cr ₹35.05 Cr ₹39.96 Cr ₹35.2 Cr ₹19.92 Cr ₹15.85 Cr
Other Comprehensive Income ₹6.05 Cr ₹60.39 Lakh -₹1.16 Cr ₹56.77 Lakh -₹79.72 Lakh -₹42.71 Lakh -₹1.16 Cr ₹2.56 Cr -₹2.23 Cr -₹1 Lakh -₹87.92 Lakh ₹1.09 Cr
Total Comprehensive Income ₹26.17 Cr ₹24.1 Cr ₹13.21 Cr ₹8.63 Cr ₹11.11 Cr ₹22.26 Cr ₹30.77 Cr ₹37.61 Cr ₹37.73 Cr ₹35.19 Cr ₹19.04 Cr ₹16.94 Cr
EBITDA (computed) ₹32.13 Cr ₹45.82 Cr ₹32.58 Cr ₹23.04 Cr ₹33.3 Cr ₹36.45 Cr ₹47.7 Cr ₹51.68 Cr ₹60.12 Cr ₹54.77 Cr ₹32.6 Cr ₹26.89 Cr
Basic EPS ₹0.37 ₹0.43 ₹0.26 ₹0.15 ₹0.20 ₹0.41 ₹0.60 ₹0.69 ₹0.78 ₹0.69 ₹0.39 ₹0.31
Diluted EPS ₹0.37 ₹0.43 ₹0.26 ₹0.15 ₹0.20 ₹0.41 ₹0.60 ₹0.69 ₹0.78 ₹0.69 ₹0.39 ₹0.31
Latest 12 quarters shown of 24 on record.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Morepen Laboratories Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Morepen Laboratories Limited

As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 35.65%, foreign institutional investors hold 1.58%, domestic institutional investors hold 1.25%, retail and other public shareholders hold 61.50% of Morepen Laboratories Limited. The company had 447,286 shareholders on record.

Promoters: 35.65%DII (Domestic Institutional): 1.25%FII (Foreign Institutional): 1.58%Retail & Others: 61.50%
Mar 2026
QUARTER
35.65% Promoters
1.25% DII (Domestic Institutional)
1.58% FII (Foreign Institutional)
61.50% Retail & Others
Promoter holding - history
Now 35.65% · Mar 2026High 38.38% · Mar 2022Low 34.54% · Dec 2015
33%34.8%36.5%38.3%40%Dec 2015Jun 2018Dec 2020Mar 2023Jun 2025Dec 2015: 34.54%Mar 2016: 34.54%Jun 2016: 34.54%Sep 2016: 34.54%Dec 2016: 34.54%Mar 2017: 34.54%Jun 2017: 34.54%Sep 2017: 34.54%Dec 2017: 34.54%Mar 2018: 34.54%Jun 2018: 34.54%Sep 2018: 34.54%Dec 2018: 34.54%Mar 2019: 34.54%Jun 2019: 34.54%Sep 2019: 34.54%Dec 2019: 34.54%Mar 2020: 34.54%Jun 2020: 34.54%Sep 2020: 34.54%Dec 2020: 34.54%Mar 2021: 34.54%Jun 2021: 34.54%Sep 2021: 34.54%Dec 2021: 34.54%Mar 2022: 38.38%May 2022: 36.74%Jun 2022: 36.74%Sep 2022: 38.22%Dec 2022: 38.22%Mar 2023: 38.22%Jun 2023: 38.22%Sep 2023: 38.22%Dec 2023: 38.22%Mar 2024: 38.22%Jun 2024: 38.22%Aug 2024: 35.65%Sep 2024: 35.65%Dec 2024: 35.65%Mar 2025: 35.65%Jun 2025: 35.65%Sep 2025: 35.65%Dec 2025: 35.65%Mar 2026: 35.65%38.38%34.54%35.65%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Promoters35.65%35.65%35.65%35.65%35.65%35.65%
Public64.35%64.35%64.35%64.35%64.35%64.35%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016
Promoters35.65%35.65%38.22%38.22%38.38%34.54%34.54%34.54%34.54%34.54%34.54%
Public64.35%64.35%61.78%61.78%61.62%65.46%65.46%65.46%65.46%65.46%65.46%
Promoter change (YoY, %pts)+0.00-2.57+0.00-0.16+3.84+0.00+0.00+0.00+0.00+0.00-

Board & Governance of Morepen Laboratories Limited

As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Morepen Laboratories Limited has 6 directors - 4 independent and 2 executive. The board is chaired by SUSHIL SURI.

DirectorPositionOn board sinceListed boards
SUSHIL SURI Executive Director · MD · Chairperson 1992-04-10 1
SANJAY SURI Executive Director 2019-08-13 1
PRAVEEN KUMAR DUTT Non-Executive - Independent Director 2019-08-13 1
RANJIT KHATTAR Non-Executive - Independent Director 2024-08-12 1
SHARAD JAIN Non-Executive - Independent Director 2024-08-27 1
SAVITA Non-Executive - Independent Director 2020-06-22 2
Board Committees
CommitteeMembers
Audit Committee PRAVEEN KUMAR DUTT (Chairperson), RANJIT KHATTAR, SHARAD JAIN
Nomination and remuneration committee PRAVEEN KUMAR DUTT (Chairperson), RANJIT KHATTAR, SHARAD JAIN
Stakeholders Relationship Committee PRAVEEN KUMAR DUTT (Chairperson), SUSHIL SURI, SAVITA
Risk Management Committee PRAVEEN KUMAR DUTT (Chairperson), SUSHIL SURI, RANJIT KHATTAR
Corporate Social Responsibility Committee SUSHIL SURI (Chairperson), PRAVEEN KUMAR DUTT, SAVITA
Finance Committee SUSHIL SURI (Chairperson), PRAVEEN KUMAR DUTT, SANJAY SURI
QIP Issue Committee PRAVEEN KUMAR DUTT (Chairperson), RANJIT KHATTAR, SHARAD JAIN

Group Structure of Morepen Laboratories Limited

Morepen Laboratories Limited has 6 subsidiary companies. This group structure data is as of FY 2025. The corporate group structure reflects Morepen Laboratories Limited's business expansion strategy and organizational complexity.

6
Subsidiary companies
Key Subsidiaries
Company Name CIN Shares Held
Morepen Rx Limited U21001HP2023PLC009940 -
Dr. Morepen Limited U24232DL2001PLC111636 -
Total Care Limited U24246DL2000PLC105296 -
Morepen Medipath Limited U32509HP2025PLC011337 -
Morepen Devices Limited U33112HP2021PLC008798 -
Quick Med Private Limited U46497HR2025PTC129787 -

Showing major subsidiaries. Total: 6.

Charges & Borrowings of Morepen Laboratories Limited

Open charges
₹61.36 Cr
Satisfied charges
₹2,644.6 Cr
Breakdown by lending institutions
Others₹61.36 Cr
Latest charge details
DateLenderAmountStatus
31 Jan 2026 Others ₹31 Lakh Open
28 Dec 2025 Others ₹1.22 Cr Open
23 May 2025 Others ₹50 Cr Open
22 Apr 2025 Others ₹56.5 Lakh Open
29 Mar 2025 Others ₹28.4 Lakh Open

Total charge records: 120 View all charges

Employees and EPFO Compliance at Morepen Laboratories Limited

Morepen Laboratories Limited has a workforce of 557 employees as of Sep 23, 2025.

Employee count
557
Active EPFO establishments
1
Employee growth
9.65%
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Morepen Laboratories Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Morepen Laboratories Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Morepen Laboratories Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Morepen Laboratories Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Morepen Laboratories Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Morepen Laboratories Limited

MSME Payment Delays by Morepen Laboratories Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Morepen Laboratories Limited

Subsidiaries & Group Companies of Morepen Laboratories Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Morepen Laboratories Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Morepen Laboratories Limited

MCA Filings & Documents of Morepen Laboratories Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Morepen Laboratories Limited

Charges
20 Mar 2026
A charge registered on 27 Dec 2024 via Charge ID 101029026 with Others was fully satisfied on 20 Mar 2026.
Charges
31 Jan 2026
A charge with Others amounted to Rs. 0.31 Cr with Charge ID 101239522 was registered on 31 Jan 2026.
Charges
09 Jan 2026
A charge registered on 09 Nov 2022 via Charge ID 100645478 with Others was fully satisfied on 09 Jan 2026.
Charges
09 Jan 2026
A charge registered on 25 Oct 2022 via Charge ID 100654072 with Others was fully satisfied on 09 Jan 2026.
Charges
28 Dec 2025
A charge with Others amounted to Rs. 1.22 Cr with Charge ID 101220140 was registered on 28 Dec 2025.
Activity
06 Sep 2025
Morepen Laboratories Limited last Annual general meeting of members was held on 06 Sep 2025 as per latest MCA records.

Recent News on Morepen Laboratories Limited

Markets rally on global cues; Bank stocks lead 1.5% surge
18 Mar 2025 · Thehindubusinessline

Frequently Asked Questions about Morepen Laboratories Limited

Morepen Laboratories Limited is an active public limited company in the pharma sector based in Himachal Pradesh, Himachal Pradesh, India. It was incorporated on 01 December 1984 (42+ years old) and is registered under CIN L24231HP1984PLC006028. Listed on BSE: 500288 and NSE: MOREPENLAB. The company has 557 employees.

Morepen Laboratories Limited reported revenue of ₹1,829.94 Cr for FY 2025 (up 7.00% YoY).

The current directors of Morepen Laboratories Limited are:

The primary industry of Morepen Laboratories Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.

Yes. Morepen Laboratories Limited is listed on both BSE (code: 500288) and NSE (symbol: MOREPENLAB).

Morepen Laboratories Limited can be reached at the registered office: Village Morepen Nalagarh Road Near Baddi Distt Solan, Himachal Pradesh, Himachal Pradesh, India – 173205, or through the website morepen.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available